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5a-reductase 2 deficiency (5ARD) is a known cause of
46,XY disorders of sex development. Classical biochem-
ical hallmarks include a normal to high male level of
serum testosterone, low level of dihydrotestosterone
(DHT) and a raised testosterone/DHT ratio at baseline
and/or after human chorionic gonadotropin stimulation.
However, equivocal results are not uncommonly encoun-
tered, potentially misleading the diagnosis and therefore
wrong sex assignment. Our objective is to propose
laboratory diagnostic algorithms other than measuring
DHT for diagnosing 5ARD. A retrospective review was
conducted on all our local 5ARD patients with urinary
steroid profiling (USP) or SRD5A2 genetic testing per-
formed. Literature review was also carried out on all the
reported 5ARD cases in the past ten years. A total of 16
local 5ARD patients were studied. Fifteen patients were
diagnosed by USP, with characteristically low 5a- to 5b-
reduced steroid metabolite ratios. Since insignificant
amount of 5a- and 5b-reduced steroid metabolites is
excreted under three months of age, a neonate had the
genetic testing performed directly. Altogether, 12 patients
underwent mutational analysis of the SRD5A2 gene, all
had two mutations detected to confirm the diagnosis.
Four patients had DHT measured, with one of them
reaching the diagnostic cutoff of 5ARD after human
chorionic gonadotropin-stimulation. A hundred and
forty-three 5ARD patients were reported in 23 publica-
tions in the review period. Ninety-five percent of them
had two mutations detected to confirm the diagnosis.
Less than half of all these patients had DHT tested. With
the high mutation detection rate in 5ARD patients, we
propose analysing the SRD5A2 gene in all newborns with
46,XY DSD for an early diagnosis before sex assignment
and any surgical intervention. When USP is readily avail-
able, it should also be used as a first-line test to guide
subsequent blood testing. In conclusion, 5ARD can
be confidently diagnosed by mutational analysis of the
SRD5A2 gene and by USP. Testing the DHT level is not
essential to the diagnosis of this condition. The role of
this hormone test in diagnosing 5ARD has been over-
emphasized.
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